2135 Bevacizumab (bev) combined with chemotherapy as first-line treatment in patients (pts) with advanced colorectal cancer: Final results from a large non-interventional community-based study. (September 2015) - Hildebrandt, B.; Broszeit-Luft, S.; Bruch, H.R.; Zimber, J.; Hahn, L.; LUck, A.; Kroening, H.; Tondar, S.; Kutscheidt, A.